Evidence map›Paper›PMID 41837697›Full record

ReviewAntimicrobial agents and chemotherapy2026

Deciphering the multidrug resistance paradigm in

Darian J Santana, Nicholas C Cauldron, P David Rogers, Christina A Cuomo

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Antimicrobial agents and chemotherapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Darian J Santana *Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.ORCID 0000-0002-5847-8352
Nicholas C Cauldron *Department of Molecular Microbiology and Immunology, Brown University, Providence, Rhode Island, USA.ORCID 0000-0003-0311-070X
P David Rogers *Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.ORCID 0000-0002-4401-0679
Christina A Cuomo *Department of Molecular Microbiology and Immunology, Brown University, Providence, Rhode Island, USA.ORCID 0000-0002-5778-960X

Funding

Mapping the genomic and molecular mechanisms of antifungal resistance in the emerging fungal pathogen Candida aurisR01AI169066 · NIAID · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI Christina A Cuomo, P. David Rogers · 2023 to 2026
$4.9M
Training in the Design and Development of Infectious Disease TherapeuticsT32AI106700 · NIAID · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI Richard E. Lee · 2015 to 2026
$2.1M
TAC1 Tango: Evolutionary rewiring of a transcriptional circuit for azole drug resistance in Candida aurisF32AI194727 · NIAID · BROWN UNIVERSITY · PI CAULDRON, NICHOLAS · 2025 to 2025
$76k
National Institute of Allergy and Infectious Diseases 5T32AI106700National Institute of Allergy and Infectious Diseases AI169066-01A1National Institute of Allergy and Infectious Diseases F32AI19727NIAID NIH HHS F32 AI194727NIAID NIH HHS R01 AI169066NIAID NIH HHS T32 AI106700
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antifungal AgentsCandidaCandida aurisDrug Resistance, Multiple, FungalCandidiasisEchinocandinsFluconazoleHumansMicrobial Sensitivity TestsMutationTriazolesAntifungal AgentsEchinocandinsFluconazoleTriazolesCandida aurisdrug resistancefungal genetics

Identifiers

PMID41837697
PMCPMC13041361

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.